辛伐他汀在心律失常治疗中的应用研究  

Analysis on Simvastatin Application in Arrhythmia

作　　者：陈文燕 

机构地区：[1]黑龙江省肇源县中医院,166500

出　　处：《中国卫生标准管理》2015年第33期78-79,共2页China Health Standard Management

摘　　要：目的探究心律失常患者采用辛伐他汀治疗的方法和效果。方法选取2014年3月~2015年8月收治的54例心律失常患者进行治疗,随机分组,实验组28例给予辛伐他汀的治疗,对照组26例患者给予美托洛尔治疗,对比患者治疗后身体症状的改善。结果实验组治疗总有效率为96.43%,对照组治疗总有效率为80.8%。实验组患者的治疗效果更好,差异有统计学意义（P〈0.05）。实验组不良反应率为3.6%,对照组不良反应率为15.4%,和实验组相比对照组患者出现不良反应患者数较多,差异有统计学意义（P〈0.05）。结论心律失常患者采用辛伐他汀治疗,能减少房性期前和室性期前的收缩次数,避免或减少不良反应的发生,效果明确。Objective To explore the treatment method and effect of Simvastatin in arrhythmia. Methods 54 patients with arrhythmia who were treated in hospital from March 2014 to August 2015 and separated them into study group and control group randomly. 28 patients in study group are given Simvastatin treatment, while 26 patients in control group were given Metoprolol treatment, and then compared patients＇ physical improvements between two groups. Results Patients＇ treatment efficacy in study group was 96.43%, which was higher than 80.8% in control group, and such a differential has statistic value（P〈0.05）; besides, adverse reactions incidence in study group was 3.6%, which was greatly lower than 15.4% in control group, thus, cases of side-effect in control group were much more than counterparts in study group, and such a differential has statistic value（P〈0.05）.Conclusion Simvastatin is effective in treatment of patients with arrhythmia, it is conducive to reducing atrial premature and ventricular premature contractions, preventing and decreasing adverse reactions.

关 键 词：心律失常 辛伐他汀 治疗效果 

分 类 号：R541.7[医药卫生—心血管疾病]